Predictive Technology Group, Inc. (PREDQ)

Market Cap	317.00
Revenue (ttm)	19.17M -44.9%
Net Income	-68.15M
EPS	-0.23
Shares Out	316.67M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	-0.44
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About PREDQ

Predictive Technology Group, Inc., together with its subsidiaries, develops and commercializes discoveries and technologies involved in novel molecular diagnostic, therapeutic, and human cellular and tissue-based products (HCT/Ps). It operates in two segments, Human Cellular and Tissues Products (HCT/Ps); and Diagnostics and Therapeutics. The company provides FertilityDX, a genetic testing service for couples experiencing infertility; ARTguide, a genetic test for women experiencing infertility because of endometriosis and other genetic conditio...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 63
• Stock Exchange: OTCMKTS
• Ticker Symbol: PREDQ

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 19, 2026

Data Sources Report a data error